FDA — authorised 11 March 1955
- Marketing authorisation holder: FRESENIUS KABI USA
- Status: approved
🇺🇸 Nesacaine-Mpf in United States
FDA authorised Nesacaine-Mpf on 11 March 1955
Marketing authorisations
FDA — authorised 11 March 1955
- Application: NDA009435
- Marketing authorisation holder: FRESENIUS KABI USA
- Local brand name: NESACAINE-MPF
- Indication: INJECTABLE — INJECTION
- Status: approved
Nesacaine-Mpf in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Pain approved in United States
Frequently asked questions
Is Nesacaine-Mpf approved in United States?
Yes. FDA authorised it on 11 March 1955; FDA authorised it on 11 March 1955.
Who is the marketing authorisation holder for Nesacaine-Mpf in United States?
FRESENIUS KABI USA holds the US marketing authorisation.